Basel Medical Group Ltd (BMGL)

Basel Medical Group Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct 17, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	29	-	-	-
Enterprise Value	25	-	-	-
Debt / Equity Ratio	0.74	0.76	1.31	2.74
Debt / EBITDA Ratio	17.43	2.14	2.82	3.34
Debt / FCF Ratio	-	2.28	2.78	3.76
Asset Turnover	0.63	0.64	0.61	-
Inventory Turnover	68.63	70.66	67.92	-
Quick Ratio	1.60	0.55	0.63	0.63
Current Ratio	1.88	2.26	2.28	2.18
Return on Equity (ROE)	6.10%	31.77%	38.79%	-
Return on Assets (ROA)	-1.21%	8.44%	7.77%	-
Return on Capital (ROIC)	-1.45%	10.29%	9.43%	-
Return on Capital Employed (ROCE)	-	23.40%	22.50%	25.50%

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q